<p>On this episode of the Pharmacy Insights podcast, host Scott Draeger welcomes Optum Rx SVP of Industry Relations,  Jamey Millar and Optum Rx SVP of formulary management, Savitha Vivian to discuss the implications of new biosimilar alternatives to expensive biologic drugs. </p>

On this episode of the Pharmacy Insights podcast, host Scott Draeger welcomes Optum Rx SVP of Industry Relations, Jamey Millar and Optum Rx SVP of formulary management, Savitha Vivian to discuss the implications of new biosimilar alternatives to expensive biologic drugs.

<p>On this episode of the Pharmacy Insights podcast, host Scott Draeger welcomes Optum Rx SVP of Industry Relations, &nbsp;Jamey Millar and Optum Rx SVP of formulary management, Savitha Vivian to discuss the implications of new biosimilar alternatives to expensive biologic drugs.&nbsp;</p>

Biosimilars boom: The next era of adoption

Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.

Share Biosimilars boom: The next era of adoption

Sign up to save your podcasts

Biosimilars boom: The next era of adoption

Biosimilars boom: The next era of adoption

More shows like Pharmacy Insights Podcast

Up First from NPR

Crime Junkie

CorConsult Rx: Evidence-Based Medicine and Pharmacy